nsclc, stage iiia
Showing 1 - 4 of 4
NSCLC Stage II, NSCLC, Stage IIIA Trial in Goyang-si (Erlotinib)
Active, not recruiting
- NSCLC Stage II
- NSCLC, Stage IIIA
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center
Apr 4, 2022
NSCLC, Stage IIIA, EGF-R Negative NSCLC, ALK Negative NSCLC Trial in Shanghai (PD-1 and chemo)
Recruiting
- NSCLC, Stage IIIA
- +2 more
- PD-1 and chemotherapy
-
Shanghai, Shanghai, ChinaShanghai General Hospital
Dec 14, 2021
NSCLC Stage II, NSCLC, Stage IIIA, NSCLC Stage IIIB Trial in Heidelberg (Atezolizumab)
Recruiting
- NSCLC Stage II
- +2 more
-
Heidelberg, BaWü, GermanyThoraxklinik Heidelberg gGmbH
Apr 25, 2021
Non Small Cell Lung Cancer, NSCLC, NSCLC Trial in Tampa (dietary supplement, radiation, drug, other)
Withdrawn
- Non Small Cell Lung Cancer
- +6 more
- Impact® Advanced Recovery
- +6 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 9, 2020